Rather & Kittrell, Inc. Humacyte, Inc. Transaction History
Rather & Kittrell, Inc.
- $507 Million
- Q3 2025
A detailed history of Rather & Kittrell, Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Rather & Kittrell, Inc. holds 17,350 shares of HUMA stock, worth $28,454. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,350
Previous 17,350
-0.0%
Holding current value
$28,454
Previous $36,000
16.67%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
166Shares Held
54.4MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$11.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$7.2 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$5.63 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$4.84 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $169M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...